2nd Quarter - Report

VAN HEUVELEN STRATEGIES, LLC for ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)

Period 2nd Quarter 2018 Filed Jul 20, 2018 Signed by Robert Van Heuvelen

Official filing
Firm
VAN HEUVELEN STRATEGIES, LLC
Client
ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to implementation of the FDA user fee reauthorization bill Issues related to the 340B drug discount program Issues related to the Inter Partes Review (IPR) process Hatch-Waxman Integrity Act of 2018

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.